Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Revenue (2023 - 2025)

Camp4 Therapeutics' Revenue history spans 3 years, with the latest figure at $348000.0 for Q4 2025.

  • For Q4 2025, Revenue fell 46.63% year-over-year to $348000.0; the TTM value through Dec 2025 reached $3.5 million, up 436.5%, while the annual FY2025 figure was $3.5 million, 436.5% up from the prior year.
  • Revenue for Q4 2025 was $348000.0 at Camp4 Therapeutics, down from $795000.0 in the prior quarter.
  • Across five years, Revenue topped out at $1.5 million in Q2 2025 and bottomed at -$83000.0 in Q4 2023.
  • The 3-year median for Revenue is $652000.0 (2024), against an average of $631000.0.
  • The largest annual shift saw Revenue surged 885.54% in 2024 before it plummeted 46.63% in 2025.
  • A 3-year view of Revenue shows it stood at -$83000.0 in 2023, then soared by 885.54% to $652000.0 in 2024, then tumbled by 46.63% to $348000.0 in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Revenue are $348000.0 (Q4 2025), $795000.0 (Q3 2025), and $1.5 million (Q2 2025).